Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-α-stimulated gene-6) in murine models of experimental arthritis

American Journal of Pathology

Volumn 159, Issue 5, 2001, Pages 1711-1721

  Bárdos, Tamás ^a   Kamath, Rajesh V ^b   Mikecz, Katalin ^a,b   Glant, Tibor T ^a,b  

^a RUSH UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CELL ADHESION MOLECULE; CELL RECEPTOR; CHONDROPROTECTIVE AGENT; CYTOKINE; HERMES ANTIGEN; HYALURONIC ACID; METALLOPROTEINASE; PROTEIN TSG 6; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BONE EROSION; CARTILAGE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; EDEMA; FEMALE; HUMORAL IMMUNITY; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0035157815     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63018-0     Document Type: Article

References (54)

1. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts
2. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44
3. TSG-6: A TNF-, IL-l-, and LPS-inducible secreted glycoprotein associated with arthritis
4. Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes
5. Up-regulation and differential expression of the hyaluronan-binding protein TSG-6 in cartilage and synovium in rheumatoid arthritis and osteoarthritis
6. Solution structure of the link module: A hyaluronanbinding domain involved in extracellular matrix stability and cell migration
7. A widespread module in developmentally regulated proteins
8. TSG-6: An IL-1/TNF-inducible protein with anti-inflammatory activity
9. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-α-inhibitor
10. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis
11. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-α-inhibitor and exerts a strong anti-inflammatory effect in vivo
12. Inter-α-trypsin inhibitor proteoglycan family-a group of proteins binding and stabilizing the extracellular matrix
13. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-l-inducible protein
14. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis
15. Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage
16. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology
17. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis
18. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice
19. Development of a peptide inhibitor of hyaluronanmediated leukocyte trafficking
20. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis
21. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis
22. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage
23. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: Application to catabolism in situ and in vitro
24. A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis
25. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice. Evidence of genetically acquired resistance to autoimmune disease
26. Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)induced arthritis
27. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion
28. Growth factor and cytokine-regulated hyaluronan -binding protein TSG-6 is localized to the injury-induced rat neointima and confers enhanced growth in vascular smooth muscle cells
29. Activation of the TSG-6 gene by NF-IL6 requires two adjacent NF-IL6 binding sites
30. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids
31. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity
32. Measurement of an adhesion molecule as an indicator of inflammatory disease activity Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis
33. Elevated TSG-6 as a biochemical marker of rheumatoid arthritis
34. Granuloma formation induced in mice by chemically defined mycobacterial fractions
35. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect in situ blocking in murine antigen- and zymosan-induced arthritis
36. Proteoglycan (aggrecan)induced arthritis in BALB/c mice is a Thl-type disease regulated by Th2 cytokines
37. Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis
38. Immunomodulation of proteoglycan-induced progressive polyarthritis by leflunomide
39. IL-4 and IL-10 treatment of proteoglycan-induced arthritis
40. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction
41. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats
42. Interleukin 6 is required for the development of collagen-induced arthritis
43. Interleukin 6 plays a key role in the development of antigen-induced arthritis
44. Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
45. Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis
46. Mechanisms for pro matrix metalloproteinase activation
47. On the inhibition of elastase by serum. Some distinguishing properties of alpha1-antitrypsin and alpha2-macroglobulin
48. Human inter-alpha-inhibitor family in inflammation simultaneous synthesis of positive and negative acute-phase proteins
49. Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues
50. Demonstration of an active component of inter-alpha-trypsin inhibitor in the brains of Alzheimer type dementia
51. Plasma inter-alpha-trypsin inhibitorrelated urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line
52. Trypsin-inhibitory activities of acid-stable fragments of the inter-alpha-trypsin inhibitor in inflammatory and uraemic conditions
53. The source of the inter-alpha trypsin inhibitor in pathologic hyaluronateprotein
54. Binding of haptoglobin, inter-αtrypsin inhibitor, and α, proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals